Dorsomedial hypothalamus CRF type 1 receptors selectively modulate inhibitory avoidance responses in the elevated T-maze

Behavioural Brain Research

Volumn 271, Issue , 2014, Pages 249-257

  Silva, Mariana S C F ^a   Pereira, Bruno A ^a   Céspedes, Isabel C ^a   Nascimento, Juliana O G ^a   Bittencourt, Jackson C ^b   Viana, Milena B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Corticotropin releasing factor; CRF; Dorsomedial hypothalamus; Elevated T maze; Panic

Indexed keywords

A 8727; ANTALARMIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ELEVATED T-MAZE TEST; ESCAPE BEHAVIOR; GENERALIZED ANXIETY DISORDER; LOCOMOTION; MALE; NONHUMAN; PANIC; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; TRANQUILIZING ACTIVITY; ANIMAL; ANTAGONISTS AND INHIBITORS; ANXIETY; DRUG EFFECTS; DRUG THERAPY; HYPOTHALAMUS; MAZE TEST; MOTOR ACTIVITY; WISTAR RAT;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; CORTICOTROPIN-RELEASING HORMONE; ESCAPE REACTION; HYPOTHALAMUS; MALE; MAZE LEARNING; MOTOR ACTIVITY; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 84903585751     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.06.018     Document Type: Article

References (57)

1. Levine S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology 2005, 30:939-946.
2. Ito M., Miyata M. Corticotropin-releasing factor (CRF) and its role in the central nervous system. Results Probl Cell Differ 1999, 26:43-66.
3. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004, 44:525-557.
4. Guillemin R. Hypothalamic hormones a.k.a. hypothalamic releasing factors. J Endocrinol 2005, 184(1):11-28.
5. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36(3):165-186.
6. Merchenthaler I. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984, 1:53-69.
7. Bangasser D.A. Sex differences in stress-related receptors: "micro" differences with "macro" implications for mood and anxiety disorders. Biol Sex Differ 2013, 4:1-13.
8. Bale T.L., Lee K., Vale W.W. The role of corticotropin-releasing factor receptors in stress and anxiety. Integr Comp Biol 2002, 42:552-555.
9. Fekete E.M., Zorrilla E.P. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol 2007, 28(1):1-27.
10. Fekete E.M., Zhao Y., Li C., Sabino V., Vale W.W., Zorrilla E.P. Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA. Neuroscience 2009, 162(1):5-13.
11. Thompson R.H., Swanson L.W. Organization of inputs to the dorsomedial nucleus of the hypothalamus: a reexamination with fluorogold and PHAL in the rat. Brain Res Brain Res Rev 1998, 27(2):89-118.
12. Canteras N.S. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol Biochem Behav 2002, 71(3):481-491.
13. Silveira M.C., Graeff F.G. Defense reaction elicited by microinjection of kainic acid into the medial hypothalamus of the rat: antagonism by a GABAA receptor agonist. Behav Neural Biol 1992, 57(3):226-232.
14. Shekhar A., Keim S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J Neurosci 1997, 17(24):9726-9735.
15. Dielenberg R.A., Hunt G.E., McGregor I.S. When a rat smells a cat: the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 2001, 104(4):1085-1097.
16. Santos J.M., Macedo C.E., Brandao M.L. Gabaergic mechanisms of hypothalamic nuclei in the expression of conditioned fear. Neurobiol Learn Mem 2008, 90:560-568.
17. da Silva E.S., Poltronieri S.C., Nascimento J.O., Zangrossi H.Jr., Viana M.B. Facilitation of 5-HT(2A/2C)-mediated neurotransmission in the ventromedial hypothalamic nucleus decreases anxiety in the elevated T-maze. Behav Brain Res 2011, 216(2):692-698.
18. Hess W.R., Brugger M. [Das subkortikale Zentrum der affektiven abwehrreacktion]. Helv Physiol Pharmacol Acta 1943, 1:33-52.
19. Fernandez de Molina A., Hunsperger R.W. Organization of the subcortical system governing defence and flight reactions in the cat. J Physiol 1962, 160:200-213.
20. Panksepp J. Aggression elicited by electrical stimulation of the hypothalamus in albino rats. Physiol Behav 1971, 6(4):321-329.
21. Bailey T.W., Dimicco J.A. Chemical stimulation of the dorsomedial hypothalamus elevates plasma ACTH in conscious rats. Am J Physiol Regul Integr Comp Physiol 2001, 280(1):R8-R15.
22. Schmitt P., Carrive P., Di Scala G., Jenck F., Brandao M., Bagri A., Moreau J.L., Sandner G. A neuropharmacological study of the periventricular neural substrate involved in flight. Behav Brain Res 1986, 22(2):181-190.
23. Nascimento J.O., Zangrossi H.Jr., Viana M.B. Effects of reversible inactivation of the dorsomedial hypothalamus on panic- and anxiety-related responses in rats. Braz J Med Biol Res 2010, 43(9):869-873.
24. Kawano H., Daikoku S., Shibasaki T. CRF-containing neuron systems in the rat hypothalamus: retrograde tracing and immunohistochemical studies. J Comp Neurol 1988, 272(2):260-268.
25. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000, 428(2):191-212.
26. Lowry C.A., Burke K.A., Renner K.J., Moore F.L., Orchinik M. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm Behav 2001, 39(3):195-205.
27. Shekhar A., Johnson P.L., Fitz S.D., Nakazato A., Chaki S., Steckler T., Schmidt M. A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responses. Int J Neuropsychopharmacol 2011, 14(3):355-365.
28. Takahashi L.K. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci Biobehav Rev 2001, 25(7-8):627-636.
29. Blanchard D.C., Blanchard R.J. Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol 1988, 39:43-68.
30. McNaughton N., Gray J.A. Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. J Affect Disord 2000, 61(3):161-176.
31. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 2004, 28(3):285-305.
32. Deakin J.F., Graeff F.G. 5-HT and mechanisms of defence. J Psychopharmacol 1991, 5(4):305-315.
33. Zangrossi H.Jr., Graeff F.G. Serotonin in anxiety and panic: contributions of the elevated T-maze. Neurosci Biobehav Rev 2014.
34. Graeff F.G., Viana M.B., Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz J Med Biol Res 1993, 26(1):67-70.
35. Viana M.B., Tomaz C., Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 1994, 49(3):549-554.
36. Graeff F.G., Zangrossi H. Animal models of anxiety. Biological psychiatry 2002, 879-893. John Wiley & Sons, London. H. D'Haenen, J.A. Den Boer, P. Willner (Eds.).
37. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol Biochem Behav 2000, 65(4):571-576.
38. Poltronieri S.C., Zangrossi H.Jr., de Barros Viana M. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res 2003, 147(1-2):185-192.
39. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2008, Elsevier Academic Press, Amsterdam; Boston, MA.
40. Sena L.M., Bueno C., Pobbe R.L., Andrade T.G., Zangrossi H.Jr., Viana M.B. The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats. Behav Brain Res 2003, 142(1-2):125-133.
41. Lukkes J.L., Forster G.L., Renner K.J., Summers C.H. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. Eur J Pharmacol 2008, 578(2-3):185-193.
42. Foster M.T., Warne J.P., Ginsberg A.B., Horneman H.F., Pecoraro N.C., Akana S.F., Dallman M.F. Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint. Endocrinology 2009, 150(5):2325-2333.
43. Pivina S.G., Akulova V.K., Ordyan N.E. Characteristics of behavior and stress reactivity of the hypophyseal-adrenocortical system in rats with prenatal inhibition of testosterone metabolism. Neurosci Behav Physiol 2007, 37(1):53-58.
44. Diniz L., Dos Reis B.B., de Castro G.M., Medalha C.C., Viana M.B. Effects of chronic corticosterone and imipramine administration on panic and anxiety-related responses. Braz J Med Biol Res 2011, 44(10):1048-1053.
45. Miguel T.T., Gomes K.S., Nunes-de-Souza R.L. Contrasting effects of nitric oxide and corticotropin-releasing factor within the dorsal periaqueductal gray on defensive behavior and nociception in mice. Braz J Med Biol Res 2012, 45(4):299-307.
46. Vicentini J.E., Céspedes I.C., Nascimento J.O., Bittencourt J.C., Viana M.B. CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze. Horm Behav 2014, 65(3):195-202.
47. Pardo-Bellver C., Cádiz-Moretti B., Novejarque A., Martínez-García F., Lanuza E. Differential efferent projections of the anterior, posteroventral, and posterodorsal subdivisions of the medial amygdala in mice. Front Neuroanat 2012, 6:33.
48. Dayas C.V., Buller K.M., Day T.A. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur J Neurosci 1999, 11(7):2312-2322.
49. Diniz L., dos Santos T.B., Britto L.R., Céspedes I.C., Garcia M.C., Spadari-Bratfisch R.C., Medalha C.C., de Castro G.M., Montesano F.T., Viana M.B. Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis. Behav Brain Res 2013, 238:170-177.
50. Herdade K.C., Strauss C.V., Zangrossi H.Júnior, Viana M.B. Effects of medial amygdala inactivation on a panic-related behavior. Behav Brain Res 2006, 172(2):316-323.
51. Roy-Byrne P.P., Uhde T.W., Post R.M., Gallucci W., Chrousos G.P., Gold P.W. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 1986, 143(7):896-899.
52. 2 inhalation study. Am J Psychiatry 2006, 163(4):738-740.
53. 2 challenge induced HPA axis activation in panic. Int J Neuropsychopharmacol 2007, 10(6):797-804.
54. Klein D.F. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 1993, 50(4):306-317.
55. Coplan J.D., Pine D., Papp L., Martinez J., Cooper T., Rosenblum L.A., Gorman J.M. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients. Neuropsychopharmacology 1995, 13(1):65-73.
56. Graeff F.G., Garcia-Leal C., Del-Ben C.M., Guimarães F.S. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?. An Acad Bras Cienc 2005, 77(3):477-491.
57. Graeff Frederico Guilherme, Zangrossi Hélio.Jr. The hypothalamic-pituitary-adrenal axis in anxiety and panic. Psychol Neurosci 2010, 3(1):3-8.